Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Revenue (2016 - 2025)

Rockwell Medical's Revenue history spans 16 years, with the latest figure at $18.3 million for Q4 2025.

  • For Q4 2025, Revenue fell 25.62% year-over-year to $18.3 million; the TTM value through Dec 2025 reached $69.3 million, down 31.76%, while the annual FY2025 figure was $69.3 million, 31.76% down from the prior year.
  • Revenue reached $18.3 million in Q4 2025 per RMTI's latest filing, up from $15.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $28.3 million in Q3 2024 to a low of $15.1 million in Q2 2021.
  • Average Revenue over 5 years is $19.5 million, with a median of $18.7 million recorded in 2022.
  • Peak YoY movement for Revenue: skyrocketed 42.88% in 2024, then crashed 43.75% in 2025.
  • A 5-year view of Revenue shows it stood at $15.3 million in 2021, then grew by 25.97% to $19.3 million in 2022, then increased by 14.39% to $22.1 million in 2023, then increased by 11.64% to $24.7 million in 2024, then fell by 25.62% to $18.3 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Revenue are $18.3 million (Q4 2025), $15.9 million (Q3 2025), and $16.1 million (Q2 2025).